Association Between Kidney Clearance of Secretory Solutes and Cardiovascular Events: The Chronic Renal Insufficiency Cohort (CRIC) Study-Reference-Cited by-同舟云学术

Association Between Kidney Clearance of Secretory Solutes and Cardiovascular Events: The Chronic Renal Insufficiency Cohort (CRIC) Study

Published:2021-08 Issue:2 Volume:78 Page:226-235.e1
ISSN:0272-6386
Container-title:American Journal of Kidney Diseases
language:en
Short-container-title:American Journal of Kidney Diseases

Author:

Chen Yan,Zelnick Leila R.,Huber Matthew P.,Wang Ke,Bansal Nisha,Hoofnagle Andrew N.,Paranji Rajan K.,Heckbert Susan R.,Weiss Noel S.,Go Alan S.,Hsu Chi-yuan,Feldman Harold I.,Waikar Sushrut S.,Mehta Rupal C.,Srivastava Anand,Seliger Stephen L.,Lash James P.,Porter Anna C.,Raj Dominic S.,Kestenbaum Bryan R.,Appel Lawrence J.,He Jiang,Rao Panduranga S.,Rahman Mahboob,Townsend Raymond R.

Funder

National Institutes of Health

Publisher

Elsevier BV

Subject

Nephrology

Reference58 articles.

1. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization;Go;N Engl J Med,2004

2. Cystatin C and the risk of death and cardiovascular events among elderly persons;Shlipak;N Engl J Med,2005

3. Cardiovascular mortality risk in chronic kidney disease: comparison of conventional and novel risk factors;Shlipak;JAMA,2005

4. Morphology of coronary atherosclerotic lesions in patients with end-stage renal failure;Schwarz;Nephrol Dial Transplant,2000

5. The impact of conventional and non-conventional risk factors on coronary calcification in pre-dialysis patients;Tomiyama;Nephrol Dial Transplant,2006

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Loop diuretics inhibit kynurenic acid production and kynurenine aminotransferases activity in rat kidneys;Pharmacological Reports;2024-09-11

2. The mechanisms underlying acute myocardial infarction in chronic kidney disease patients undergoing hemodialysis;Biomedicine & Pharmacotherapy;2024-08

3. Cardiovascular Consequences of Uremic Metabolites: an Overview of the Involved Signaling Pathways;Circulation Research;2024-03

4. Effects of Empagliflozin on Gut Microbiota in Heart Failure with a Preserved Ejection Fraction: The Design of a Pragmatic Randomized, Open-Label Controlled Trial (EMPAGUM);Drug Design, Development and Therapy;2023-05

5. Estimated Kidney Tubular Secretion and Kidney, Cardiovascular, and Mortality Outcomes in CKD: The Systolic Blood Pressure Intervention Trial;Kidney Medicine;2022-12